2019
SJR Q3
JCR Q4 · 0,1
1 matched articles
ESCI
Journal detail
Phlebolymphology (discontinued)
- Publisher
- Servier International
- Country
- France · Western Europe
- Type
- journal
- ISSN
-
12860107
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,215
- Quartile Q3
- H-Index 15
- Cites/doc 0,9
- Docs (3y) 32
- Cites (3y) 19
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,1
- 5Y JIF 0,1
- JCI 0,03
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q3
Areas
- Medicine
WoS categories
- Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | — | Q4 | — | 0,1 | 0,1 | 0,03 | Q4 | — |
| 2024 | — | Q4 | — | 0,2 | 0,2 | 0,05 | Q4 | — |
| 2023 | — | Q4 | — | 0,2 | 0,3 | 0,04 | Q4 | — |
| 2022 | — | — | — | 0,2 | 0,3 | 0,04 | Q4 | — |
| 2021 | — | — | — | — | — | 0,05 | Q4 | — |
| 2020 | — | — | — | — | — | 0,05 | Q4 | — |
| 2019 | Q3 | — | 0,215 | — | — | — | — | 15 |
| 2017 | Q4 | — | 0,168 | — | — | — | — | 15 |
| 2016 | Q3 | — | 0,181 | — | — | — | — | 15 |
| 2015 | Q3 | — | 0,181 | — | — | — | — | 15 |
| 2014 | Q3 | — | 0,187 | — | — | — | — | 15 |
| 2013 | Q4 | — | 0,119 | — | — | — | — | 15 |
| 2012 | Q4 | — | 0,115 | — | — | — | — | 15 |
| 2011 | Q4 | — | 0,124 | — | — | — | — | 15 |
| 2010 | Q3 | — | 0,177 | — | — | — | — | 15 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | ESCI | Q4 | Q4 | 99/100 |
| 2024 | PERIPHERAL VASCULAR DISEASE | ESCI | Q4 | Q4 | 96/98 |
| 2023 | PERIPHERAL VASCULAR DISEASE | ESCI | Q4 | Q4 | 93/96 |
| 2022 | PERIPHERAL VASCULAR DISEASE | ESCI | — | Q4 | — |
| 2021 | PERIPHERAL VASCULAR DISEASE | ESCI | — | Q4 | — |
| 2020 | PERIPHERAL VASCULAR DISEASE | ESCI | — | Q4 | — |